Table 6. Comparison of top 10 cancer incidence in two different periods in urban Beijing, China (2011-2012 vs. 1998-1999).
| Rank | Male |
Female |
|||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1998-1999 |
2011-2012 |
1998-1999 |
2011-2012 |
||||||||||
| Site | Cases | ASR | Site | Cases | ASR | Site | Cases | ASR | Site | Cases | ASR | ||
| 1 | Lung (C33-C34) | 3,267 | 35.89 | Lung (C33-C34) | 6,087 | 36.71 | Breast (C50) | 2,424 | 26.53 | Breast (C50) | 5,749 | 42.92 | |
| 2 | Liver (C22) | 1,478 | 16.63 | Colorectum (C18-C21) | 3,523 | 22.35 | Lung (C33-C34) | 2,003 | 20.89 | Lung (C33-C34) | 3,941 | 22.31 | |
| 3 | Stomach (C16) | 1,504 | 16.54 | Liver (C22) | 2,198 | 14.93 | Colorectum (C18-C21) | 1,158 | 12.29 | Colorectum (C18-C21) | 2,809 | 16.58 | |
| 4 | Colorectum (C18-C21) | 1,333 | 14.64 | Stomach (C16) | 2,157 | 13.2 | Stomach (C16) | 672 | 7.03 | Thyroid (C73) | 1,934 | 17.29 | |
| 5 | Esophagus (C15) | 849 | 9.2 | Prostate (C61) | 1,863 | 10.47 | Liver (C22) | 531 | 5.62 | Uterus (C54-C55) | 1,329 | 9.79 | |
| 6 | Bladder (C67) | 533 | 5.91 | Kidney (C64-C66,68) | 1,420 | 9.93 | Ovary (C56) | 468 | 5.41 | Ovary (C56) | 918 | 6.94 | |
| 7 | Kidney (C64-C66,68) | 463 | 5.23 | Bladder (C67) | 1,368 | 8.27 | Uterus (C54-C55) | 425 | 4.58 | Stomach (C16) | 1,058 | 6.6 | |
| 8 | Lymphoma (C81-C85,88,90,96) | 410 | 4.96 | Lymphoma (C81-C85,88,90,96) | 906 | 6.53 | Esophagus (C15) | 351 | 3.58 | Kidney (C64-C66,68) | 929 | 5.86 | |
| 9 | Pancreas (C25) | 426 | 4.7 | Esophagus (C15) | 963 | 6.01 | Pancreas (C25) | 317 | 3.31 | Lymphoma (C81-C85,88,90,96) | 771 | 5.43 | |
| 10 | Prostate (C61) | 381 | 4.08 | Pancreas (C25) | 863 | 5.47 | Kidney (C64-C66,68) | 278 | 2.99 | Liver (C22) | 799 | 4.75 | |
ASR, age-standardized rates.